| Authors: |
Thomas CE; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States., Wesselink E; Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Takashima Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Huyghe JR; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States., Buchanan DD; Colorectal Oncogenomics Group, Department of Clinical Pathology, Melbourne Medical School, The University of Melbourne, Parkville, Australia.; Collaborative Centre for Genomic Cancer Medicine, The University of Melbourne, Victorian Comprehensive Cancer Centre, Parkville, Australia.; Genomic Medicine and Family Cancer Clinic, The Royal Melbourne Hospital, Parkville, Victoria, Australia., Grant RC; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Costa AD; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States., Ugai T; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States., Ogino S; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States.; Institute of Science Tokyo, Tokyo, Japan., Nowak JA; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Peters U; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States.; Department of Epidemiology, University of Washington, Seattle, Washington, United States., Phipps AI; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States.; Department of Epidemiology, University of Washington, Seattle, Washington, United States., Hsu L; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States.; Department of Biostatistics, University of Washington, Seattle, Washington, United States. |
